Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.23 USD | -5.38% | -3.91% | +123.64% |
Kurzporträt
Mitarbeiterzahl: 73
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22.05.19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01.10.22 | |
Chief Operating Officer | 42 | 01.03.21 | |
Uli Bialucha
CTO | Chief Tech/Sci/R&D Officer | - | 01.04.21 |
Scott Coleman
PRN | Corporate Officer/Principal | - | 01.06.22 |
Stacey J. Davis
PRN | Corporate Officer/Principal | - | 17.05.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23.07.20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01.12.20 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 15.09.22 |
Sara Bonstein
BRD | Director/Board Member | 43 | 17.08.21 |
Robert Ross
BRD | Director/Board Member | 50 | 16.06.22 |
René Russo
CEO | Chief Executive Officer | 49 | 22.05.19 |
Christina Rossi
BRD | Director/Board Member | 48 | 01.04.21 |
Yuan Xu
BRD | Director/Board Member | 56 | 04.01.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 34 479 103 | 23 477 593 ( 68,09 %) | 5 617 ( 0,0163 %) | 68,09 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+123.64% | 42.4 Mio. | |
-1.78% | 41.36 Mrd. | |
+45.38% | 41.3 Mrd. | |
+4.01% | 39.61 Mrd. | |
-15.14% | 25.62 Mrd. | |
+3.16% | 24.09 Mrd. | |
-24.08% | 18.38 Mrd. | |
-2.67% | 11.82 Mrd. | |
+24.76% | 11.85 Mrd. | |
+7.01% | 11.07 Mrd. |
- Börse
- Aktien
- A3C53B Aktie
- Unternehmen Xilio Therapeutics, Inc.